BIA
CVS icon

Benchmark Investment Advisors’s CVS Health CVS Stock Holding History

Benchmark Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,894
Closed -$615K – 81
2023
Q2 		$615K Buy
8,894
+1,404
+19% +$99.9K 0.57% 52
2023
Q1 		$557K Sell
7,490
-10
-0.1% -$839 0.57% 52
2022
Q4 		$699K Buy
+7,500
New +$724K 0.74% 48

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Benchmark Investment Advisors's CVS Position: Q3 2023 in Review

Benchmark Investment Advisors sold out of CVS Health (CVS) in Q3 2023, closing a stake of 8,894 shares — an estimated $615K sold.

Benchmark Investment Advisors first reported a position in CVS in Q4 2022 and held it in 3 quarters. The position peaked at $699K in Q4 2022. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Benchmark Investment Advisors reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Benchmark Investment Advisors sold 8,894 CVS Health shares in Q3 2023, an estimated $615K.
  • Benchmark Investment Advisors first reported a position in CVS Health in Q4 2022 and held it in 3 quarters.
  • Benchmark Investment Advisors's CVS Health position peaked at $699K in Q4 2022.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Benchmark Investment Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.